CX Aortic Vienna—now less than 4 weeks away!
cxsymposium2022-05-17T19:25:25+01:00Afshin Assadian (Vienna, Austria), current president of the Austrian Society for Vascular Surgery, Alexander Zimmermann (Zurich, Switzerland) and Roberto Chiesa (Milan, Italy) share what to expect from the upcoming CX Aortic Vienna LIVE Virtual Conference, a comprehensive meeting on aortic therapies.
Look ahead to CX Aortic Vienna in September
cxsymposium2022-05-17T19:14:53+01:00Roger Greenhalgh (London, UK) invites you to CX Aortic Vienna, which will run from 8–11 September 2020. The programme will cover open and endovascular aortic interventions from the aortic valve to the iliac arteries. All known pathologies will be included and imaging and diagnostic aspects will be applied systematically […]
Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
cxsymposium2020-02-10T11:07:13+00:00
Recorded presentation from CX Symposium 2019
Hence Verhagen, Rotterdam, Netherlands
Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy
cxsymposium2019-09-06T16:25:29+01:00Recorded presentation from CX Symposium 2019
Bijan Modarai, London, United Kingdom
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
cxsymposium2019-09-06T16:26:34+01:00Recorded presentation from CX Symposium 2019
Marc Schermerhorn, Boston, United States
CX Special Session will discuss the use of paclitaxel devices
cxsymposium2019-09-06T16:37:19+01:00CX Executive Board Members Gunnar Tepe and Thomas Zeller introduce the CX Special Session which aims to give the last word on paclitaxel and work with the vascular community to find the way forward.
Watch the video below, and see the final CX 2019 programme here.
[…]
CX 2019: Vascular EDUCATION as it should be
cxsymposium2020-02-14T14:51:28+00:00CX is Europe’s largest and longest-running vascular symposium and delivers vascular EDUCATION as it should be
CX raises CONTROVERSIES, CHALLENGES the evidence to reach CONSENSUS in a three yearly cycle after discussion involving a world-class faculty and expert audience.
CX uses both live cases and edited cases from leading aortic, peripheral and venous centres to illustrate […]
CX 2019 Vascular Access Programme Highlights
cxsymposium2019-09-06T16:38:16+01:00Nicholas Inston, member of the CX Vascular Access Executive Board, gives the highlights for this year’s CX Vascular Access Masterclass which will focus on the maintenance and not just the formation of vascular access.
CX 2019: Stephen Black on the Venous Challenges programme
cxsymposium2019-09-06T16:41:17+01:00Stephen Black, member of the CX Venous Executive Board, describes the wonderful opportunity that the Charing Cross Venous Challenges Programme offers as it brings together key developments in the science, learning experience in the Venous Village and input from the international faculty who share their vision.
CX 2019 Venous Challenges and educational activities
cxsymposium2019-09-06T16:43:10+01:00Manj Gohel, member of the CX Venous Executive Board, previews some of the fantastic educational activity that is being planned for CX 2019.
CX 2019 Peripheral Challenges Programme Highlights
cxsymposium2019-09-06T16:44:08+01:00From new outcomes of paclitaxel-coated devices to DCB use below the knee, the CX Peripheral Executive Board looks ahead to CX 2019 and raises some of the key questions that will be addressed in the programme.
Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
cxsymposium2019-09-09T09:16:45+01:00Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Ulf Teichgräber, Jena, Germany
EVAS is associated with a reduction in all-cause mortality
cxsymposium2019-09-09T09:19:47+01:00EVAS is associated with a reduction in all-cause mortality
Marc Schermerhorn, Boston, United States
Podium 1st: Lutonix AV IDE interim 24 month update
cxsymposium2018-04-26T13:27:11+01:00Podium 1st: Lutonix AV IDE interim 24 month update
Kate Steiner, Stevenage, United Kingdom
CX 2017 “Drive to get Consensus”: Andrew Holden on what makes CX so special
cxsymposium2017-02-04T03:56:25+00:00What are the special features of the CX Symposium? CX Programme Organising Board member Andrew Holden (Associate Professor of Radiology at Auckland University School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand) highlights the discussion, debate and “a drive to get consensus”.